Abstract
In many cases, development of insulin resistance has been linked to obesity and may contribute to mechanism of aging. The role of diet, irrespective of degree of obesity, in modulating insulin resistance and development of age degeneration disease remains uncertain. Lowered blood glucose levels are commonly associated with diet restriction (DR), which is an intervention shown to successfully retard aging and age associated disease. The effects of DR on blood glucose and insulin resistance were measured in yellow obese (Avy/A), lean black (a/a) mice and in another common inbred strain (B6C3F1) (at three different ages). The yellow obese mice become diabetic as a result of an insulin receptor defect which is not clearly understood. Insulin responses and radioinsulin binding were assayed in yellow obese and lean black mice fed either ad libitum (AL) or DR diets (YAL, BAL, YDR and YAL, respectively) at four different circadian intervals. The B6C3F1 controls were fed either AL (CAL) or DR (CDR) and measures were made at six circadian stages and three different ages. Within 23 days, DR produced a significant loss in body weight and a time-dependent 22–55% reduction in basal blood glucose levels in the yellow obese mice. Additionally, exogenous insulin produced circadian stage dependent (at the time of food intake) reductions in blood glucose in the YDR animals that were not present in YAL animals. 125I-Insulin binding in liver was increased nearly 2-fold in YDR and BDR mice during the time of day that animals were active and eating. 125I-Insulin binding was two-fold-higher in CDR mice at 4, 12 and >24 months of age. Binding decreased as a function of age in both the CAL and CDR animals. However, even in the >24 month group the CDR animals were found to have levels of binding that were as high as those found in younger CAL liver. The mechanism of action appears to be through resolution of insulin resistance by modulating an insulin receptor defect.
Full Text
The Full Text of this article is available as a PDF (625.3 KB).
References
- Alemzadeh R., Jacob W., Pitukcheewanont P. Antiobesity effect of diazoxide in obese Zucker rats. Metabolism: Clin. & Exper. 1996;45(3):334–41. doi: 10.1016/s0026-0495(96)90287-5. [DOI] [PubMed] [Google Scholar]
- Cooney G.J., Storlien L.H. Insulin action, thermogenesis and obesity. Baill. Clin. Endo. & Metab. 1994;8(3):481–507. doi: 10.1016/S0950-351X(05)80283-6. [DOI] [PubMed] [Google Scholar]
- DeFronzo R.A. Pharmacologic therapyfor type 2 diabetes mellitus. Annals Internal Med. 1999;131(4):281–303. doi: 10.7326/0003-4819-131-4-199908170-00008. [DOI] [PubMed] [Google Scholar]
- Duffy P.H., Feuers R.J., Leakey J.A., Turturro A., Hart R.W. Effect of Chronic Caloric Restriction on Physiological Variables Related to Energy Metabolism in the Male Fischer 344 Rat. Mech. Ageing Dev. 1989;48:117–133. doi: 10.1016/0047-6374(89)90044-4. [DOI] [PubMed] [Google Scholar]
- Duffy P.H., Feuers R.J., Hart R.W. Effect of chronic caloric restriction on the circadian regulation of physiological and behavioral variables in the male B5C3F1 mouse. Chronobiology International. 1990;7:291–303. doi: 10.1080/07420529009064635. [DOI] [PubMed] [Google Scholar]
- Duffy P.H., Feuers R.J., Nakamura K., Leakey J.E.A., Hart R.W. Effect of chronic caloric restriction on the synchronization of various physiological measures in old female Fischer 344 rats. Chronobiology International. 1990;7:113–124. doi: 10.3109/07420529009056963. [DOI] [PubMed] [Google Scholar]
- Duffy P.H., Feuers R.J. Biomarkers of Aging: Changes in Circadian Rhythms Related to the Modulation of Metabolic Output. Biomed. Environ. Sc. 1991;4:182–191. [PubMed] [Google Scholar]
- Duffy P.H., Feuers R.J., Leakey J.E.A., Hart R.W. Chronic caloric restriction in old female mice: Changes in the circadian rhythms of physiological and behavioral variables. In: Fishbein L., editor. Bio. Eff. of Diet. Res. NY: Springer-Verlag; 1991. pp. 245–263. [Google Scholar]
- Ebling P., Koivisto V.A. Physiological importance of dehydroepiandrosterone. Lancet. 1994;343:1479–1481. doi: 10.1016/S0140-6736(94)92587-9. [DOI] [PubMed] [Google Scholar]
- Falkner B., Michel S. Obesity and other risk factors in children. Ethnicity & Disease. 1999;9(2):284–9. [PubMed] [Google Scholar]
- Feuers R.J., Duffy P.H., Leakey J.E.A., Turturro A., Mittelstadt R.A., Hart R.W. Effect of chronic caloric restriction on hepatic enzymes of intermediary metabolism in male Fischer 344 rats. Mech. Age Develop. 1989;48:179–189. doi: 10.1016/0047-6374(89)90049-3. [DOI] [PubMed] [Google Scholar]
- Feuers R.J., Hunter J.D., Duffy P.H., Leakey J.E.A., Hart R.W., Scheving L.E. 125I-Insulin binding in liver and affects of insulin on glucose homeostasis in calorically restricted mice. Ann. Rev. Chronobiology. 1990;7:95–98. [Google Scholar]
- Feuers, RJ, Hunter, JD, Duffy, PH, Leakey, JEA, Hart, RW, and Scheving, LE: 125I-Insulin binding in liver and the influence of insulin on blood glucose in calorically restricted B6C3F1 male mice. In: A. Reinberg and M. Smolensky (eds.), Ann. Rev. of Chronopharmacology, Paragon Press, 189–192, 1990b.
- Feuers R.J. The relationship of dietary restriction to circadian variation in physiological parameters and regulation of metabolism. Aging. 1991;3(4):399–401. doi: 10.1007/BF03324048. [DOI] [PubMed] [Google Scholar]
- Frame L.T., Hart R.W., Leakey J.E. Caloric restriction as a mechanism mediating resistance to environmental disease. Env. Health Persp. 1998;106(Suppl1):313–24. doi: 10.1289/ehp.98106s1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Golay A., Felber J.P. Evolution of obesity to diabetes. Diabete et Metab. 1994;20(1):3–14. [PubMed] [Google Scholar]
- Grundy S.M. Multifactorial causation of obesity: implications for prevention. Am. J. Clin. Nutr. 1998;67(3Suppl):563S–72S. doi: 10.1093/ajcn/67.3.563S. [DOI] [PubMed] [Google Scholar]
- Halberg F., Johnson E.A., Nelson W., Runge W., Sothern R. Autorhythmometry — procedures for physiological self-measurements and their analysis. Physiol. Teach. 1972;1:1–11. [Google Scholar]
- Hodge A.M., Zimmet P.Z. The epidemiology of obesity. Baill. Clin. Endo. and Metab. 1994;8(3):577–599. doi: 10.1016/S0950-351X(05)80287-3. [DOI] [PubMed] [Google Scholar]
- Hotamisligil G.S. The role TNF alpha and TNF receptors in obesity and insulin resistance. J. Int. Med. 1999;245(6):621–5. doi: 10.1046/j.1365-2796.1999.00490.x. [DOI] [PubMed] [Google Scholar]
- Hsueh W.A., Buchanan T.A. Obesity and hypertension. Endocr. & Metabol. Clin. of N. Am. 1994;23(2):405–427. [PubMed] [Google Scholar]
- Ilarde A., Tuck M. Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review. Drugs & Aging. 1994;4(6):470–491. doi: 10.2165/00002512-199404060-00004. [DOI] [PubMed] [Google Scholar]
- Jha R.J. Thiazolidinediones—the new insulin enhancers. Clin. and Exper. Hypertension (New York) 1999;21(1–2):157–66. doi: 10.3109/10641969909068658. [DOI] [PubMed] [Google Scholar]
- Johannsson G., Bengtsson B.A. Growth hormone and metabolic syndrome. J. Endo. Invest. 1999;22(5Suppl):41–6. [PubMed] [Google Scholar]
- Kopelman P.G. Hormones and obesity. Baill. Clin. Endo. and Metab. 1994;8(3):549–575. doi: 10.1016/S0950-351X(05)80286-1. [DOI] [PubMed] [Google Scholar]
- Lanoue K.F., Martin L.F. Abnormal A1 adenosine receptor function in genetic obesity. FASEB J. 1994;8(1):72–80. doi: 10.1096/fasebj.8.1.8299893. [DOI] [PubMed] [Google Scholar]
- Leakey J.E.A., Cunny H.C., Bazare J., Webb P., Lipscomb J.C., Slikker W., Feuers R.J., Duffy P.H., Hart R.W. Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in Fischer 344 rats. Mech. Age Develop. 1989;48:145–155. doi: 10.1016/0047-6374(89)90046-8. [DOI] [PubMed] [Google Scholar]
- Lebovitz H.E. Type 2 diabetes: an overview. Clinical Chemistry. 1999;45(8Pt2):1339–45. [PubMed] [Google Scholar]
- Maegawa H., Kashiwagi A. Molecular mechanism and clinical impact of insulin resistance in type 2 diabetes mellitus. Nippon Rinsho — Japanese J. of Clin. Med. 1999;57(3):539–44. [PubMed] [Google Scholar]
- Masoro E.J. Possible mechanisms underlying the antiaging actions of caloric restriction. Toxicologic Pathology. 1996;24(6):738–41. doi: 10.1177/019262339602400617. [DOI] [PubMed] [Google Scholar]
- McGarry J.D. Disordered metabolism in diabetes: have we underemphasized the fat component? J. Cell. Biochem. 1994;55(Suppl):29–38. doi: 10.1002/jcb.240550005. [DOI] [PubMed] [Google Scholar]
- Meehan W.P., Darwin C.H., Maalouf N.B., Buchanan T.A., Saad M.F. Insulin and hypertension: are they related? Przegkad Lekarski. 1994;51(3):135–148. [PubMed] [Google Scholar]
- Roth G.S., Ingram D.K., Lane M.A. Caloric restriction in primates: will it work and how will we know? J. Am. Ger. Soc. 1999;47(7):896–903. doi: 10.1111/j.1532-5415.1999.tb03851.x. [DOI] [PubMed] [Google Scholar]
- Scheen A.J., Luyckx F.H. Medical aspects of obesity. Acta Chirurgica Belgica. 1999;99(3):135–9. [PubMed] [Google Scholar]
- Shafrin E. Development and consequences of insulin resistance-lessons from animals with hyperinsulinemia. Diabetes and Metab. 1996;22(2):122–131. [PubMed] [Google Scholar]
- Smith U. Carbohydrates, fat, and insulin action. Am.J. of Clin. Nutr. 1994;59(3Suppl):686S–689S. doi: 10.1093/ajcn/59.3.686S. [DOI] [PubMed] [Google Scholar]
- Weindruch R., Wallford R.L. The retardation of aging and disease by dietary restriction. Springfield, IL: Charles C. Thomas; 1988. [Google Scholar]
- Weindruch R., Lane M.A., Ingram D.K., Ershler W.B., Roth G.S. Dietary restriction in rhesus monkeys: lymphopenia and reduced mitogen-induced proliferation in peripheral blood mononuclear cells. Aging. 1997;9(4):304–8. doi: 10.1007/BF03341833. [DOI] [PubMed] [Google Scholar]
